| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 424688000 | Oxide or hydroxide | 34 |
| 20100143502 | PLANT WASH - A plant wash comprising a mixture of dormant oil and hop extract in a carrier is useful for protecting fruit trees against freeze damage, bacterium, pest infestations, fungi and wilt. | 06-10-2010 |
| 20110217390 | Method of manufacturing digestible powder that generates hydride ion (H-) - A method of manufacturing digestible powder that generates a hydride ion (H | 09-08-2011 |
| 20160106884 | IMPLANT WITH CONTROLLED POROSITY COMPRISING A MATRIX COVERED BY A BIOACTIVE GLASS OR BY A HYBRID MATERIAL - The disclosure relates to an implant material for filling bone defects, for bone regeneration and for bone tissue engineering, to an implant comprising this material, and to a method for producing such an implant. The implant material comprises: a bioactive glass M based on SiO | 04-21-2016 |
| 424689000 | With stabilizer or suspending agent | 1 |
| 20140186472 | COMPOSITION AND METHOD FOR IMPROVING GASTROINTESTINAL HEALTH OF EQUINE - A composition to moderate excessive and potentially harmful gastric acid levels in the gastrointestinal tract of horses is disclosed. The composition includes calcium oxide and/or calcium hydroxide, which may be in combination with various buffers and other ingredients such as sodium bicarbonate, sodium bentonite, sodium sesquicarbonate, calcium carbonate, magnesium oxide, omega-3 and omega-6 fatty acid sources, simple carbohydrates, and/or probiotics. A method of administering the composition is also disclosed. | 07-03-2014 |
| 424690000 | Aluminum hydroxide | 6 |
| 20090130232 | Composition and method for treatment of oral inflammation an ulceration - The present invention is a composition and method for treating oral lesions. | 05-21-2009 |
| 20110318432 | COMPOSITIONS FOR THE TREATMENT OF GASTRO-ESOFAGEAL REFLUX DISEASE (GERD) - Oral pharmaceutical, nutraceutical, health foods and medical device compositions based on polysaccharides from | 12-29-2011 |
| 20120027876 | Composition and Method for the Topical Treatment of Dermatitis - A composition for topical treatment of dermatitis is provided. The composition includes one or more anti-histamines or a pharmaceutically acceptable salt thereof; one or more polysaccharides; and one or more Group 1, 2, or 13 metal hydroxides. The dermatitis may be a poison ivy, poison oak, poison sumac, diaper rash, eczema, lichen simplex chronicus, rashes, dermatoses, seborrheic dermatitis, psoriasis, atopic dermatitis, or the combination thereof. A method of treatment of dermatitis is also provided. | 02-02-2012 |
| 20130243888 | Composition and Method for the Topical Treatment of Dermatitis - A composition for topical treatment of dermatitis is provided. The composition includes one or more anti-histamines or a pharmaceutically acceptable salt thereof; one or more polysaccharides; and one or more Group 1, 2, or 13 metal hydroxides. The dermatitis may be a poison ivy, poison oak, poison sumac, diaper rash, eczema, lichen simplex chronicus, rashes, dermatoses, seborrheic dermatitis, psoriasis, atopic dermatitis, or the combination thereof A method of treatment of dermatitis is also provided. | 09-19-2013 |
| 20150086649 | METHODS FOR NUCLEAR REPROGRAMMING OF CELLS - Described herein are methods for enhancing the nuclear reprogramming of somatic cells to become induced pluripotent stem cells. In particular, the methods disclosed herein involve the use of damage-associated molecular pattern molecules (DAMP). In certain embodiments the DAMPs are aluminum compositions such as aluminum hydroxide. Such DAMPs have unexpectedly and surprisingly been found to enhance the nuclear reprogramming efficiency of the reprogramming factors commonly used to induce somatic cells to become induced pluripotent stem cells. Accordingly, this disclosure describes methods of nuclear reprogramming as well as cells obtained from such methods along with therapeutic methods for using such cells for the treatment of disease amendable to treatment by stem cell therapy; as well as kits for such uses. | 03-26-2015 |
| 20160058669 | TOPICAL PHARMACEUTICAL COMPOUNDS AND METHODS - Methods to enable a visual check on the mixing proper pharmaceutical compounding kits. The methods include providing a kit with a colored inactive to be added to the mixture. When the mixture is uniform or resembles a predetermined color, the mixture is assumed to be properly mixed. | 03-03-2016 |
| 424691000 | Aluminum oxide | 2 |
| 20100040701 | COMPOUND FOR EXFOLIATING SKIN - A novel exfoliating compound and method for treating acne without an irritating cleanser. The compound includes a first subcompound formed from a clay based substance and a second subcompound formed an exfoliating substance selected from the group consisting of crystals, beads, polyethylene, nuts, natural rough products, corundum crystals, crushed almond shells and crushed apricot kernels. | 02-18-2010 |
| 20140178502 | METHOD FOR PREVENTING AND TREATING MASTITIS - When a rock powder which contains silicic acid and aluminum oxide as active ingredients is given to livestock animals, nitrogen compounds including ammonia nitrogen and nitrate nitrogen generated in the body of the livestock animals can be chemically adsorbed by aluminum oxide and silicic acid, whereby the over-absorption of the nitrogen compounds through the digestive tract can be suppressed. At the same time, minor elements contained in the rock powder act to fully elicit the activity of a nutritional component capable of suppressing mastitis, e.g., vitamin A, vitamin E, copper, zinc and manganese obtained from the feed. In this manner, the onset of mastitis can be suppressed in a nutritional manner, and a therapeutic effect can be achieved on mastitis that has already been developed. | 06-26-2014 |
| 424692000 | Magnesium hydroxide or oxide | 16 |
| 20080299227 | Method for removal of HIV from the gastrointestinal tract and bile of HIV-infected subjects and for the prevention of drug failure and prevention of development of AIDS in HIV-infected subjects - The present invention discloses a novel use of magnesium oxide and magnesium hydroxide formulation in adequate proportions and sufficient amounts to induce bowel movement to induce the excretion of HIV, along with HIV-infected pathogens present in the intestinal tract of HIV-infected persons, and to induce the excretion of HIV-loaded bile from said persons. The present invention may prevent the development of drug resistance in HIV patients undergoing drug therapy, may accelerate the recovery of HIV-infected patients, may permit full recovery of these individuals, may prevent viral mutation of patients undergoing HIV drug therapy, and may prevent the onset of AIDS in HIV-infected patients. As an additional benefit, the present invention will contribute to the prevention of adipose tissue disorders, frequently seen in persons undergoing drug therapy. The present invention may be used by itself or together with HAART or other drug therapies. | 12-04-2008 |
| 20090110755 | Compositions and Methods for Preventing Migraines - The present invention relates to compositions and methods for preventing migraines. The migraine prophylaxis composition is a single dosage form comprising at least one form of elemental magnesium and at least one NSAID. The prophylaxis composition, comprising at least one form of elemental magnesium and a therapeutically effective concentration of acetylsalicylic acid may also provide cardiac protection and prevent cardiovascular diseases. | 04-30-2009 |
| 20090186099 | BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM - Buccal aerosol sprays or capsules using polar and non-polar solvent have now been developed which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention comprise formulation I: aqueous polar solvent, active compound, and optional flavoring agent; formulation II: aqueous polar solvent, active compound, optionally flavoring agent, and propellant; formulation III: non-polar solvent, active compound, and optional flavoring agent; and formulation IV: non-polar solvent, active compound, optional flavoring agent, and propellant. | 07-23-2009 |
| 20110081426 | AMINOTHIAZOLE MODULATORS OF BETA-3-ADRENORECEPTOR - The present invention relates to new aminothiazole modulators of beta-3-adrenoreceptor activity, pharmaceutical compositions thereof, and methods of use thereof. | 04-07-2011 |
| 20110135758 | Laxative and process for making same - A laxative is provided containing a mixture of prune juice, magnesium, magnesium hydroxide and purified water. | 06-09-2011 |
| 20110236508 | L-ARGININE-BASED FORMULATION FOR ORAL ABSORPTION - A formulation comprising large quantities of l-arginine and/or fat plaque dissolving agents which is palatable, stench free, and does not evoke nausea. The formulation is adapted to facilitate the adsorption of l-arginine to the blood system and to introduce high levels of l-arginine and/or other fat plaque dissolving agents such as EDTA, its derivatives or its salts into the blood system which are sufficient for effectively dissolving fat plaques in the artery. The formulation comprises at least 10% (w/w) L-arginine, edible organic acids, emulsifier(s), preservatives, flavorings, ethanol and water. Other embodiments may further include chromium salts, and EDTA or its derivatives and their salts | 09-29-2011 |
| 20110300238 | MIXTURE OF INORGANIC COMPOUNDS, PREPARATIONS CONTAINING THE MIXTURE AND USE OF THE MIXTURE - A mineral mixture including at least' MgO and its equilibrium of Mg(OH) | 12-08-2011 |
| 20140271929 | CITRATE CONTAINING BEVERAGE - Provided are beverage compositions comprising a urine citrate increasing component and a urine oxalate reducing component. The beverage compositions may be provided in a ready-to-drink form or may be provided in a concentrate form. Also provided are kits comprising the beverage compositions and methods for treating various conditions using the beverage compositions. | 09-18-2014 |
| 20140348952 | MAGNESIUM-CONTAINING PRODUCTS AND USES THEREOF - A composition including a hydrate form of magnesium oxide, denoted as MgO.(H | 11-27-2014 |
| 20140356461 | PLANT DISEASE CONTROLLING AGENT AND METHOD FOR CONTROLLING PLANT DISEASES USING SAME - To provide a plant disease controlling agent and the method for controlling plant diseases using the same, the plant disease controlling agent being commonly applicable to various crop and soil conditions, and ensures safety over a long period throughout the environment. | 12-04-2014 |
| 20150044303 | Pharmaceutical Formulations Useful for Inhibiting Acid Secretion and Methods for Making and Using Them - The present invention relates to pharmaceutical formulations comprising at least one acid-labile proton pump inhibiting agent and at least one antacid, which have improved bioavailability, chemical stability, physical stability, dissolution profiles, disintegration times, safety, as well as other improved pharmacokinetic, pharmacodynamic, chemical and/or physical properties. The present invention is directed to methods, kits, combinations, and compositions for treating, preventing or reducing the risk of developing a gastrointestinal disorder or disease, or the symptoms associated with, or related to, a gastrointestinal disorder or disease in a subject in need thereof. | 02-12-2015 |
| 20150132410 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF ALCOHOL-INDUCED HANGOVER SYNDROME - The invention provides compositions for the prevention and treatment of the symptoms of alcoholic beverage-induced hangover syndrome, related kits and methods of using the compositions and kits. | 05-14-2015 |
| 20160008334 | Preparations for the Treatment of Sleep-Related Respiratory Disorders | 01-14-2016 |
| 20160143824 | LONG-WEAR COSMETIC COMPOSITION - The present invention relates to a cosmetic composition comprising: (i) at least one oxide of an alkaline earth metal (ii) at least one metal soap, preferably a metal salt of C | 05-26-2016 |
| 20160184349 | Citrate Containing Beverage - Provided are beverage compositions comprising a urine citrate increasing component and a urine oxalate reducing component. The beverage compositions may be provided in a ready-to-drink form or may be provided in a concentrate form. Also provided are kits comprising the beverage compositions and methods for treating various conditions using the beverage compositions. | 06-30-2016 |
| 20220133778 | PHARMACEUTICAL FORMULATIONS USEFUL FOR INHIBITING ACID SECRETION AND METHODS FOR MAKING AND USING THEM - The present invention relates to pharmaceutical formulations comprising at least one acid-labile proton pump inhibiting agent and at least one antacid, which have improved bioavailability, chemical stability, physical stability, dissolution profiles, disintegration times, safety, as well as other improved pharmacokinetic, pharmacodynamic, chemical and/or physical properties. The present invention is directed to methods, kits, combinations, and compositions for treating, preventing or reducing the risk of developing a gastrointestinal disorder or disease, or the symptoms associated with, or related to, a gastrointestinal disorder or disease in a subject in need thereof. | 05-05-2022 |
| 424693000 | Calcium hydroxide | 6 |
| 20100068305 | MIXTURE FOR USE AS A WOUND DRESSING - A subject matter of the invention is a mixture, which comprises:
| 03-18-2010 |
| 20100239690 | COMPOSITION FOR ORAL CAVITY AND SKIN - A composition for oral cavity and skin which contains an antibacterial agent and does not have adverse side effects due to steroids, is provided. | 09-23-2010 |
| 20100310679 | NOVEL COMPOSITIONS FOR CONTROL OF MALICIOUS MARINE ANEMONES - The present invention relates to improved compositions for controlling marine pest anemones, to methods of application of same, and to kits for the convenient dispensing of such compositions. | 12-09-2010 |
| 20120009280 | METHOD OF REDUCING THE RATE OF DEGRADATION OF A BIOLOGICAL MATERIAL - A method of producing an animal feed product from a wet biological material, having a physical form selected from solutions, suspensions, emulsions, gums, mousses, sludges, slurries, and particulate materials, includes the step of combining the biological material with a base comprising a metal oxide in an amount which is sufficient to heat the biological material to a temperature of above 50° C. by reaction of water in the biological material with the metal oxide to produce the animal feed product. The product has a physical form which is easier to handle than that of the wet biological material and is selected from particulate materials and, granular materials. The base is preferably calcium oxide. | 01-12-2012 |
| 20150147412 | Sulfuric Acid Burn Treatment Composition - Disclosed is a composition for treating sulfuric acid burn, wherein the composition may be used as a topical medication. The composition generally includes isopropyl alcohol or L-valine solution; at least one active therapeutic substance and/or a disinfectant for treating the burn; calcium hydroxide for neutralizing the acid; a humectant and/or a clinging agent for preventing the acid from spreading; an expectorant for signaling the body to clear any irritations caused by the acid; an acid indicator for visually signaling presence of the acid; and fumed silica as a thickening agent for slowing the reaction time of the acid. In a preferred embodiment, and without limitation, the therapeutic substances may include eugenol and thymol, and the disinfectants may include turmeric powder and hydrogen peroxide. Additionally, glycerin and sugar are used as clinging agents to reduce the chemical reaction between the sulfuric acid and surrounding tissue or materials exposed thereto. | 05-28-2015 |
| 424694000 | Characterized as lime or slaked lime | 1 |
| 20100203170 | METHOD FOR FORMULATING AGROCHEMICAL ACTIVE INGREDIENTS SO AS TO REGULATE THEIR RELEASE KINETICS, PROTECT THEM FROM OUTSIDE STRESSES, AND KEEP THEIR USERS SAFE - The invention pertains to a new method for formulating any agrochemical active ingredient so as to protect the user, protect this active ingredient from outside stresses, and control its release kinetics. It relies on the use of acrylic and thickening emulsions with a pH greater than five and containing hydrophobic groups in order to trap said active ingredient. The invention also pertains to the various embodiments of the active ingredient thereby formulated: a mixture in water of that active ingredient with these thickening emotions, a dispersion of solid particles of these polymers and this active ingredient after a certification, and the solid particles obtained in a dried state after the water has been removed. Finally, the invention pertains to the use of these various formulations in order to protect and active ingredient, protect its user, and slow its release kinetics. | 08-12-2010 |
